Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$43.66 - $61.0 $1.31 Million - $1.83 Million
-30,000 Reduced 31.58%
65,000 $3.22 Million
Q1 2022

May 13, 2022

SELL
$48.25 - $100.49 $5.07 Million - $10.6 Million
-105,000 Reduced 52.5%
95,000 $6.29 Million
Q4 2021

Feb 11, 2022

SELL
$88.71 - $120.43 $443,549 - $602,150
-5,000 Reduced 2.44%
200,000 $20 Million
Q3 2021

Nov 12, 2021

BUY
$98.77 - $132.17 $2.96 Million - $3.97 Million
30,000 Added 17.14%
205,000 $25.6 Million
Q2 2021

Aug 13, 2021

SELL
$109.77 - $165.68 $5.49 Million - $8.28 Million
-50,000 Reduced 22.22%
175,000 $21.7 Million
Q1 2021

May 14, 2021

BUY
$127.04 - $179.1 $6.99 Million - $9.85 Million
55,000 Added 32.35%
225,000 $34.3 Million
Q4 2020

Jan 19, 2021

SELL
$99.96 - $135.93 $7 Million - $9.52 Million
-70,000 Reduced 29.17%
170,000 $21.9 Million
Q3 2020

Oct 13, 2020

BUY
$80.32 - $111.8 $4.42 Million - $6.15 Million
55,000 Added 29.73%
240,000 $26.8 Million
Q2 2020

Jul 16, 2020

BUY
$60.49 - $97.5 $604,900 - $975,000
10,000 Added 5.71%
185,000 $15 Million
Q1 2020

Apr 16, 2020

BUY
$59.04 - $88.81 $1.16 Million - $1.75 Million
19,732 Added 12.71%
175,000 $12.2 Million
Q4 2019

Jan 17, 2020

BUY
$59.49 - $82.78 $7.15 Million - $9.96 Million
120,268 Added 343.62%
155,268 $12.1 Million
Q3 2019

Oct 16, 2019

BUY
$62.59 - $110.3 $2.19 Million - $3.86 Million
35,000 New
35,000 $2.23 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.34B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.